[The biomonitoring of toxic substances in biological samples of general population]
Jesús Ibarluzea1, Juan José Aurrekoetxea2, Miquel Porta3
1Subdirección de Salud Pública de Gipuzkoa, Departamento de Salud del Gobierno Vasco, San Sebastián, Guipúzcoa, España; BIODONOSTIA, Instituto de Investigación Sanitaria, San Sebastián, Guipúzcoa, España; CIBER de Epidemiología y Salud Pública (CIBERESP), España.
Abstract:
Many of the world's most developed countries have adopted biomonitoring of toxic substances in order to ascertain their levels in biological samples. These substances get into the body through different environmental exposures. Monitoring toxic substances in biological samples should allow us to ascertain their levels in vulnerable groups, assess their evolution over time, make comparisons with levels observed in other countries, identify groups at risk or with high toxic levels and promote research. The main objective of biomonitoring is to act as a policy design tool to facilitate the implementation of particular measures in various sectors: health, environmental, agricultural and livestock or food industry sectors. In Spain, information on levels of toxic substances of environmental origin is provided by specific studies on health effects from environmental sources, such as the INMA project (INfancia y Medio Ambiente [childhood and environment]). In addition, biomonitoring projects have been implemented in Catalonia and the Canary Islands, together with a national biomonitoring programme in the adult working population. However, further progress is needed to develop a system that covers the general population as well as subgroups at risk, which relies on the collaboration of the involved authorities and the participation of professionals from different sectors and citizen organisations interested in the relationship between health and the environment.
Related Concept Videos
Toxicity Testing in Animals
Therapeutic Drug Monitoring: Drug Analysis Methods
Drug Concentrations: Measurements
Plasma...
Bioavailability Study Design: Healthy Subjects Versus Patients
Therapeutic Drug Monitoring: Overview and Classification
Bioactivation and Tissue Toxicity


